News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
201 Results
Type
Article (16)
Press Release (185)
Section
Business (74)
Deals (7)
Drug Development (61)
FDA (3)
Job Trends (3)
News (117)
Policy (3)
Tag
Academia (3)
Alliances (4)
Alzheimer's disease (15)
Approvals (3)
Best Places to Work (3)
Cell therapy (2)
Clinical research (48)
COVID-19 (4)
Data (4)
Diagnostics (1)
Earnings (35)
Events (63)
Executive appointments (2)
FDA (6)
Gene therapy (1)
GLP-1 (3)
Healthcare (1)
Infectious disease (4)
IPO (8)
Medical device (1)
Medtech (1)
Neurodegenerative disease (1)
Neuroscience (15)
NextGen: Class of 2025 (15)
Opinion (1)
People (25)
Phase I (21)
Phase II (38)
Phase III (6)
Pipeline (2)
Regulatory (5)
Research institute (3)
Southern California (1)
United States (33)
Date
Last 30 days (4)
Last 365 days (50)
2025 (8)
2024 (46)
2023 (34)
2022 (37)
2021 (49)
2020 (1)
2019 (6)
2018 (13)
2017 (7)
Location
Asia (3)
California (1)
Europe (6)
Florida (31)
New York (1)
Pennsylvania (1)
Southern California (1)
201 Results for "longeveron".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Longeveron® to Present at the 37th Annual Roth Conference
March 5, 2025
·
1 min read
Press Releases
Longeveron to Present at the Emerging Growth Virtual Conference on February 19, 2025
February 17, 2025
·
1 min read
Press Releases
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update
February 28, 2025
·
15 min read
Press Releases
Longeveron® to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025
February 24, 2025
·
1 min read
Press Releases
Longeveron to Present at Biotech Showcase 2025
December 18, 2024
·
1 min read
Press Releases
Longeveron® Announces Positive Type B Meeting with U.S. FDA Regarding Pathway to BLA for Laromestrocel (Lomecel-BTM) in Alzheimer’s Disease
March 20, 2025
·
9 min read
Press Releases
Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s Disease
March 12, 2025
·
10 min read
Press Releases
Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™
February 18, 2025
·
8 min read
BioMidwest
Longeveron® to Attend BIO International Convention 2024
Longeveron Inc. announced that the Company will participate in the BIO International Convention taking place June 3-6, 2024 at the San Diego Convention Center.
May 28, 2024
·
6 min read
BioMidwest
Longeveron to Present at the Planet MicroCap Showcase
Longeveron Inc. announced that it will participate in the Planet MicroCap Showcase, taking place May 1-2, 2024.
April 25, 2024
·
1 min read
1 of 21
Next
